| PERIOD ENDING | 23-Feb-09 | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 114,949 | 114,949 | 125,689 | | Cost of Revenue | 126,126 |
-
|
-
| | | Gross Profit | (11,177) | 114,949 | 125,689 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 110,890 | 110,890 | 90,364 | | Non Recurring |
-
|
-
|
-
| | Others |
-
| 126,126 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (122,067) | (122,067) | 35,325 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (120,904) | (120,904) | 35,325 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (120,904) | (120,904) | 35,325 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest | 1,163 | 1,163 |
-
| | | | Net Income From Continuing Ops | (120,904) | (120,904) | 35,325 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (120,904) | (120,904) | 35,325 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($120,904) | ($120,904) | $35,325 |
|
0.51% Nasdaq 
Income Statement
